Related Experiment Videos
Prophylactic treatment of childhood asthma
Insights
Preventing childhood asthma involves maternal diet, breastfeeding, immunotherapy, and medications like ketotifen fumarate. A study found ketotifen fumarate effectively reduced asthma symptoms and episodes with convenient twice-daily dosing.
Area of Science:
- Pediatrics
- Allergy and Immunology
- Pharmacology
Background:
- Childhood asthma presents a significant public health challenge.
- Prophylactic strategies are crucial for managing and preventing pediatric asthma.
- Current approaches include maternal interventions, immunotherapy, and chemoprophylaxis.
Purpose of the Study:
- To review prophylactic measures for childhood asthma.
- To evaluate the efficacy of ketotifen fumarate in a multicenter study.
- To assess the benefits of chemoprophylaxis in pediatric asthma management.
Main Methods:
- Literature review of asthma prophylaxis strategies.
- Multicenter clinical trial investigating ketotifen fumarate.
- Assessment of symptom reduction and acute asthmatic episodes.
Main Results:
- Ketotifen fumarate demonstrated a reduction in asthma symptoms.
- The drug significantly decreased the frequency of acute asthmatic episodes.
- Twice-daily oral administration of ketotifen fumarate proved advantageous.
Conclusions:
- Ketotifen fumarate is an effective chemoprophylactic agent for childhood asthma.
- The drug offers a convenient dosing regimen for pediatric patients.
- Comprehensive prophylaxis strategies should be considered for childhood asthma.
Abstract:
The prophylaxis of childhood asthma is discussed under the headings of prevention by the pregnant mother in avoiding hypersensitizing foods and the adherence to breast feeding, immunotherapy of the child and chemoprophylaxis by sodium cromoglycate or ketotifen fumarate. The results of a multicentre study of the latter drug are described. Ketotifen caused a reduction of symptoms and acute asthmatic episodes, and has the advantage of a twice daily oral dosage.